Has Amole Ojo, MD received payments from drug or device companies?

Yes. Drug and device makers reported $21,781 in general payments to Amole Ojo, MD across 112 transactions between 2019–2025. Most Open Payments records nationally are meals worth under $20; a reported payment is not evidence of wrongdoing.

Does a payment mean Amole Ojo, MD did something wrong?

No. Federal law requires drug and device makers to report almost every transfer of value to a physician, including a $14 sandwich at a lunch presentation. Consulting fees, research funding and royalties to device inventors are ordinary, legal parts of medicine. This site reports what was disclosed; it makes no allegation.

Where does this information about Amole Ojo, MD come from?

The U.S. Centers for Medicare & Medicaid Services. Payments come from Open Payments, published under the Physician Payments Sunshine Act. Billing and prescribing figures come from the Medicare Physician & Other Practitioners and Part D Prescriber public use files for 2024.

Amole Ojo, MD

Cardiovascular Disease · Rochester, NYNPI 1982983672

Payments from drug & device makers

$21,781in general payments, 2019–2025

Across 112 payments — averaging $194.47 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

Medtronic$8K
Boston Scientific$5K
Abbott$5K
Biotronik Inc.$2K
Biosense Webster, Inc.$500
Medical Device Business Services, Inc.$337
plus $414 from 3 others

What the payments were for

Speaking & faculty fees$2,47511%
Grants$9014%
Travel & lodging$12,68358%
Food & beverage$5,13324%
Education$5893%

General payments by program year

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

Company	Payments	Total
Medtronic(2 entities)	49	$8,488
Boston Scientific	24	$5,145
Abbott	24	$4,645
Biotronik Inc.	3	$2,251
Biosense Webster, Inc.	6	$500
Medical Device Business Services, Inc.	3	$337
Impulse Dynamics (USA) Inc.	1	$176
Abiomed	1	$131
Kestra Medical Technology Services, Inc.	1	$108

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$21,781 in reported general payments places this provider in the 85th percentile of 2,302 cardiovascular disease providers in New York.

See all cardiovascular disease providers in New York →

Medicare billing

Part B allowed, 2024

$86,716

Medicare patients

256

Services billed

782

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

Drug	Claims	Cost to plans & patients
EliquisApixaban	15	$13,527
Amiodarone Hcl	49	$1,179
Flecainide Acetate	22	$1,088
Metoprolol Succinate	30	$858

Paid to pharmacies, not to this prescriber.

Other cardiovascular disease in Rochester

James EichelbergerRochester$332K
James MinNew York$41.1M
Robert RosensonNew York$6.9M
Roxana MehranNew York$6.4M
Roger HajjarNew York$5.2M
Philippe GenereuxNew York$4.4M
Vijay IyerAmherst$4.3M
Gregg StoneNew York$3.7M
Szilard VorosStony Brook$3.7M
Valentin FusterNew York$2.9M

See the full list for New York →

Where these figures come from

Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
Identity: NPPES NPI Registry, July 2026.

Is this you, or does something look wrong? →